VRDN Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 112885 min ago

@ $18.37

Wydano: 14 vas. 2024 @ 21:55

Zwrot: -20.63%

Poprzedni sygnał: vas. 14 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: 1.83 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	835 836
Średni wolumen	907 181
Kapitalizacja rynkowa	930.53M
EPS	$0 ( 2024-03-13 )
Następna data zysków	( $-1.070 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.75
ATR14	$0.0170 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Fairmount Funds Management Llc	Buy	5 859	Common Stock
2024-03-28	Fairmount Funds Management Llc	Buy	21 999	Series A Non-Voting Convertible Preferred Stock
2024-03-28	Fairmount Funds Management Llc	Sell	5 859	Common Stock
2024-03-28	Fairmount Funds Management Llc	Sell	21 999	Series A Non-Voting Convertible Preferred Stock
2024-02-12	Tousignant Jennifer	Buy	0

INSIDER POWER
58.81
Last 95 transactions
Buy: 5 352 885 \| Sell: 1 550 540

Wolumen Korelacja

Długi: 0.05 (neutral)

Krótki: 0.82 (strong)

Signal:(69.512) Same movement expected

Viridian Therapeutics, Korelacja

10 Najbardziej pozytywne korelacje
TBNK	0.946
RGLD	0.946
MCHI	0.941
ISEM	0.939
HCM	0.938
IMVT	0.938
QFIN	0.935
PGJ	0.933
WLFC	0.932
ROIV	0.924

10 Najbardziej negatywne korelacje
LLNW	-0.934
PCRX	-0.918
SFET	-0.915
SWAV	-0.913
ASPS	-0.913
GRIN	-0.907
NKTX	-0.906
RTPY	-0.895
LAWS	-0.893
LNSR	-0.889

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Viridian Therapeutics, Korelacja - Waluta/Towar

0.16
( neutral )

0.04
( neutral )

0.00
( neutral )

0.14
( neutral )

0.40
( neutral )

Viridian Therapeutics, Finanse

Annual	2023
Przychody:	$314 000
Zysk brutto:	$-1.01M (-321.02 %)
EPS:	$-5.31

FY	2023
Przychody:	$314 000
Zysk brutto:	$-1.01M (-321.02 %)
EPS:	$-5.31

FY	2022
Przychody:	$1.77M
Zysk brutto:	$1.02M (57.39 %)
EPS:	$-3.91

FY	2021
Przychody:	$2.96M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-6.66

Financial Reports:

No articles found.

Viridian Therapeutics,

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

Aktualne aktualizacje dla Viridian Therapeutics, [VRDN]

Upcoming Earnings Alert